<?xml version="1.0" encoding="UTF-8"?>
<p>Treatment is supportive with no specific medication. Prevention of hepatitis E in endemic areas comprises of improved hygiene. The antibody is not fully protective as seen with the occurrence of large epidemics among adults living in endemic areas. Candidate vaccines have been developed and are being currently studied in Nepal. An IgG antibody was observed after the third vaccine dose although only 56 % of the volunteers had a high antibody titer by the end of the study [
 <xref ref-type="bibr" rid="CR95">95</xref>]. The vaccine may potentially be useful for travelers to endemic areas.
</p>
